Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
World
The Bamboo Works

New Drugs Approvals Bring No Relief for Ailing Innovent Bio

Key Takeaways:

  • Innovent Bio has brought several drugs to market in recent years, including two announced last week, but is still losing money with no profits in sight
  • The company has overhauled its commercialization model and is doing more licensing partnerships with multinationals to expand its drug pipeline
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.